HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 3, 2014, Pages 969-977

  Liu, Yong ^a   Zhou, Jie ^a   Zhang, Cuiwei ^a   Fu, Wenguang ^a   Xiao, Xiuli ^a   Ruan, Sibei ^a   Zhang, Yuan ^a   Luo, Xia ^a   Tang, Mingxi ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Colorectal carcinoma (CRC); HLJ1; Metastasis; Survival rate

Indexed keywords

DNAJB4 PROTEIN, HUMAN; HEAT SHOCK PROTEIN 40; TUMOR MARKER;

ADENOCARCINOMA; BIOSYNTHESIS; COLORECTAL TUMOR; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HSP40 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84899552004     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Prat A, Casado E, Cortes J. New approaches in angiogenic targeting for colorectal cancer. World J Gastroenterol 2007 Nov 28; 13: 5857-66.
2. Wang YX, Zhang XY, Zhang BF, Yang CQ, Gao HJ. Study on the clinical significance of Argonaute2 expression in colonic carcinoma by tissue microarray. Int J Clin Exp Pathol 2013; 6: 476-84.
3. Ye Z, Palazzo JP, Lin L, Lai Y, Guiles F, Myers RE, Han J, Xing J, Yang H. Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients. J Gastroenterol Hepatol 2013 Sep; 28: 1469-75.
4. Pu XX, Huang GL, Guo HQ, Guo CC, Li H, Ye S, Ling S, Jiang L, Tian Y, Lin TY. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 2010 Oct; 25: 1674-80.
5. Takasu C, Shimada M, Kurita N, Iwata T, Nishioka M, Morimoto S, Yoshikawa K, Miyatani T, Kashihara H, Utsunomiya T. Impact of C-reactive protein on prognosis of patients with colorectal carcinoma. Hepatogastroenterology 2013 May; 60: 507-11.
6. Langer T, Lu C, Echols H, Flanagan J, Hayer MK, Hartl FU. Successive action of DnaK, DnaJ and GroEL along the pathway of chaperone-mediated protein folding. Nature 1992 Apr 23; 356: 683-9.
7. Hoe KL, Won M, Chung KS, Jang YJ, Lee SB, Kim DU, Lee JW, Yun JH, Yoo HS. Isolation of a new member of DnaJ-like heat shock protein 40 (Hsp40) from human liver. Biochim Biophys Acta 1998 Mar 3; 1383: 4-8.
8. Wang CC, Tsai MF, Hong TM, Chang GC, Chen CY, Yang WM, Chen JJ, Yang PC. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion. Oncogene 2005 Jun 9; 24: 4081-93.
9. Zhang L, Cai X, Chen K, Wang Z, Wang L, Ren M, Huang A, Tang H. Hepatitis B virus protein up-regulated HLJ1 expression via the transcription factor YY1 in human hepatocarcinoma cells. Virus Res 2011 Apr; 157: 76-81.
10. Wang CC, Tsai MF, Dai TH, Hong TM, Chan WK, Chen JJ, Yang PC. Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1. Cancer Res 2007 May 15; 67: 4816-26.
11. Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 2006 Jun 21; 98: 825-38.
12. Chen HW, Lee JY, Huang JY, Wang CC, Chen WJ, Su SF, Huang CW, Ho CC, Chen JJ, Tsai MF, Yu SL, Yang PC. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 2008 Sep 15; 68: 7428-38.
13. Lai YH, Yu SL, Chen HY, Wang CC, Chen HW, Chen JJ. The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer. Carcinogenesis 2013 May; 34: 1069-80.
14. Chang TP, Yu SL, Lin SY, Hsiao YJ, Chang GC, Yang PC, Chen JJ. Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation. Cancer Res 2010 Feb 15; 70: 1656-67.
15. Shon JK, Shon BH, Park IY, Lee SU, Fa L, Chang KY, Shin JH, Lee YI. Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription. Virus Res 2009 Jan; 139: 14-21.
16. Lin SY, Hsueh CM, Yu SL, Su CC, Shum WY, Yeh KC, Chang GC, Chen JJ. HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma. Nucleic Acids Res 2010 Oct; 38: 6148-58.